Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1986-07-02
1987-12-08
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
530395, 530397, 530406, C07K 1710, A61K 39385
Patent
active
047117796
ABSTRACT:
Glycoproteinic conjugates having trivalent immunogenic activity obtained by binding, by a covalent bond, to a protein selected among CRM 197, tetanus toxoid, and pertussis toxin, at least an oligosaccharidic hapten derived from the capsular polysaccharide of a gram-positive bacterium and at least an oligosaccharidic hapten derived from the capsular polysaccharide of a gram-negative bacterium, and wherein said oligosaccharidic haptens are previously activated by introducing terminal esters.
REFERENCES:
patent: 4057685 (1977-11-01), McIntire
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4496538 (1985-01-01), Gordon
patent: 4619828 (1986-10-01), Gordon
patent: 4663160 (1987-05-01), Tsay et al.
"An Immunological Study of the Diphtheria Toxin Molecule", A. M. Pappenheimer, Jr., et al., Immunchem., vol. 9, pp. 891-906 (1972).
"Diptheria Toxin and Related Proteins", T. Uchida, et al., J. Bio. Chem., vol. 248, No. 11, pp. 3838-3844 (1973).
"Pertussis Toxin", R. D. Sekura, et al., J. Bio. Chem., vol. 258, No. 23, pp. 14647-14651 (1983).
"Large-Scale Production of Tetanus Toxoid", P. A. Nielsen, J. App. Micro., pp. 453-454 (Mar. 1967).
Costantino Paolo
Porro Massimo
Schain Howard E.
Sclavo S.p.A.
LandOfFree
Glycoproteinic conjugates having trivalent immunogenic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycoproteinic conjugates having trivalent immunogenic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycoproteinic conjugates having trivalent immunogenic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-22146